Azenta (AZTA) Other Non-Current Liabilities (2010 - 2026)
Azenta (AZTA) posted quarterly Other Non-Current Liabilities of $10.9 million for Q1 2026, up 8.25% year-over-year from $10.1 million in Q1 2025, and down 5.08% quarter-over-quarter from $11.5 million in Q4 2025.
Azenta (AZTA) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Other Non-Current Liabilities for 17 consecutive years, with $10.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 8.25% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $10.9 million (up 8.25% YoY), while the FY2025 annual figure was $11.5 million, changed N/A from the prior year.
- Other Non-Current Liabilities fell to $10.9 million in Q1 2026 per AZTA's latest filing, from $11.5 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $18.5 million in Q4 2022 and bottomed at $425000.0 in Q2 2025.
- Historically, Other Non-Current Liabilities has averaged $9.7 million across 5 years, with a median of $11.0 million in 2025.
- Annual changes were most pronounced in 2024 — Other Non-Current Liabilities jumped 729.21% — and 2025, when it slumped 96.33%.
- Azenta's Other Non-Current Liabilities stood at $18.5 million in 2022, then tumbled by 33.42% to $12.3 million in 2023, then slumped by 33.19% to $8.2 million in 2024, then jumped by 39.45% to $11.5 million in 2025, then decreased by 5.08% to $10.9 million in 2026.
- Business Quant data shows AZTA's Other Non-Current Liabilities at $10.9 million in Q1 2026, $11.5 million in Q4 2025, and $11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.73 Mn |
| Mar 31, 2026 | 10.89 Mn |
| Dec 31, 2025 | 11.48 Mn |
| Sep 30, 2025 | 11.14 Mn |
| Jun 30, 2025 | 425,000.00 |
| Mar 31, 2025 | 10.06 Mn |
| Dec 31, 2024 | 8.23 Mn |
| Sep 30, 2024 | 9.27 Mn |
| Jun 30, 2024 | 11.59 Mn |
| Mar 31, 2024 | 11.61 Mn |
| Dec 31, 2023 | 12.32 Mn |
| Sep 30, 2023 | 12.18 Mn |
| Jun 30, 2023 | 12.76 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 18.50 Mn |
| Sep 30, 2022 | 6.72 Mn |
| Mar 31, 2022 | 7.16 Mn |
| Dec 31, 2021 | 4.37 Mn |
| Sep 30, 2021 | 6.17 Mn |
| Jun 30, 2021 | 8.44 Mn |